Best GLP-1 Providers in Indiana (2026)

Compare 168 GLP-1 telehealth providers available in Indiana. Average compounded semaglutide cost: $189/mo.

168 providers$189/mo averageTelehealth legal

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Featured Partners · Indiana

Featured GLP-1 providers serving Indiana

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See by medication

Looking for a specific GLP-1? Browse Indiana providers by drug.

About GLP-1s in Indiana

Indiana allows telehealth GLP-1 prescriptions through licensed providers. Indiana Medicaid covers GLP-1s only for type 2 diabetes.

  • Indiana's adult obesity rate is 36.4%, in the top 10 nationally
  • Indiana Medicaid limits GLP-1 coverage to diabetes
  • Compounded semaglutide is widely available statewide

All GLP-1 Providers Available in Indiana

8.3/ 10
Verified partner

CoreAge Rx

Best for: best overall value

★★★★4.2/5

Editorial score · methodology

$99/mosemaglutide
$149/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
8.2/ 10
Verified partner

Enhance MD

Best for: lab-monitored compounded GLP-1 with mandatory video visit

★★★★4.1/5

Editorial score · methodology

$112/mosemaglutide
$169/motirzepatide
CompoundedSemaglutideTirzepatideNAD+
Get StartedRead full Enhance MD review →
8.1/ 10
Verified partner

bmiMD

Best for: mainstream telehealth GLP-1 access

★★★★4.1/5

Editorial score · methodology

$99/mosemaglutide
$139/motirzepatide
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full bmiMD review →
8.1/ 10
Verified partner

Pallas Health

Best for: the most complete public disclosure of pharmacies and prescribing physicians we have found

★★★★4.1/5

Editorial score · methodology

$139/mosemaglutide
$179/motirzepatide
CompoundedSemaglutideTirzepatideNAD+
Get StartedRead full Pallas Health review →
8.1/ 10
Verified partner

RxSpan MD

Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

★★★★4.1/5

Editorial score · methodology

$194/mosemaglutide
$269/motirzepatide
CompoundedSemaglutideTirzepatideGlutathioneNAD+LegitScript Verified
Get StartedRead full RxSpan MD review →
Browse all 168 providers in Indiana A–Z

Also consider: 302 providers with undisclosed state coverage

These providers offer GLP-1 weight loss service (verified on their own websites) but do not publish a complete state-availability list publicly — their intake flow determines eligibility. We have not independently confirmed Indiana coverage for the providers below. Start the signup intake to check whether they serve your state before proceeding.

8.1/ 10
Verified partner

Oak

Best for: compounded semaglutide and tirzepatide at a flat monthly price

★★★★4.1/5

Editorial score · methodology

$133/mosemaglutide
$199/motirzepatide
CompoundedSemaglutideTirzepatideGlutathioneNAD+LegitScript Verified
Get StartedRead full Oak review →
7.1/ 10
Verified partner

Bodybuilding Health+

Best for: fitness-brand compounded GLP-1 with hormone and performance programs

★★★3.6/5

Editorial score · methodology

$179/mosemaglutide
$209/motirzepatide
CompoundedSemaglutideTirzepatideGHK-CuGlutathioneLegitScript Verified
Get StartedRead full Bodybuilding Health+ review →
6.4/ 10
Verified partner

Direct Meds

Best for: listed for disclosure only — see its FDA warning and BBB complaints first

★★★☆☆3.2/5

Editorial score · methodology

$249/mosemaglutide
$299/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Direct Meds review →
8.0/ 10
Verified partner

Sesame Care

Best for: Brand-name GLP-1s at cash prices, no compounding

★★★★4/5

Editorial score · methodology

$149/mosemaglutide
$299/motirzepatide
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
6.9/ 10
Verified partner

Try Ageless

Best for: lowest-tier compounded GLP-1 in injection, troche and sublingual forms

★★★3.5/5

Editorial score · methodology

$119/mosemaglutide
$169/motirzepatide
CompoundedSemaglutideTirzepatideGonadorelinNAD+LegitScript Verified
Get StartedRead full Try Ageless review →
7.3/ 10
Verified partner

Sunlight

Best for: compounded GLP-1 with unlimited telehealth visits and free shipping

★★★3.7/5

Editorial score · methodology

$88/mosemaglutide
$157/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full Sunlight review →
Browse all 302 providers with undisclosed Indiana coverage A–Z

Top Cities for GLP-1 Treatment in Indiana

Telehealth providers ship to all Indiana addresses, but demand is highest in these metro areas:

Prefer an in-person clinic? Browse the Indiana GLP-1 clinic directory →

Insurance & Medicaid in Indiana

Indiana Medicaid GLP-1 Coverage
Diabetes only

Most insurance plans in Indiana cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), but coverage for obesity-only indications (Wegovy, Zepbound) is much more limited and often requires prior authorization. If your insurance won't cover brand-name GLP-1s, compounded semaglutide through telehealth is typically the most affordable option at around $189/mo.

For the exact criteria, drug list, and appeal process, read our Indiana Medicaid GLP-1 coverage & prior-authorization guide. For coverage backdoors, Zepbound is FDA-approved for obstructive sleep apnea, and Wegovy for kidney and cardiovascular indications, which some plans cover even when they exclude weight-loss-only use.

Obesity in Indiana

According to CDC data, 36.4% of Indiana adults have obesity (BMI of 30 or higher). This places Indiana at #9 out of 50 states. Access to GLP-1 medications like semaglutide and tirzepatide has expanded significantly through telehealth, helping Indiana residents get clinically supervised weight loss treatment from home.

To choose a medication, compare the clinical-trial results behind each drug, see our best semaglutide and tirzepatide provider rankings, or track the next-generation GLP-1 pipeline.

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Get Indiana Price Alerts

Be the first to know about new providers and price changes in Indiana.